Expertise in
1
conditions

Elise Deluche

Limoges, FR 
Expertise in
1
conditions
Limoges, FR 

Overview

Elise Deluche practices practicing medicine in Limoges, France.

Ms. Deluche is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Breast Cancer, Muscle Atrophy, Ovarian Cancer, and Prolactinoma.

She is actively involved in clinical research, co-authoring 79 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Limoges, France
Other Locations
Besancon, France
Strasbourg, France
Gustave Roussy
Villejuif, France
IUCT Oncopole
Toulouse, 31100, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: Intensified Protocol, Stupp Protocol
Study Phase: Phase 3
De-Escalation of Adjuvant Chemotherapy in HER2-positive, Estrogen Receptor-negative, Node-negative Early Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy and Dual HER2 Blockade
De-Escalation of Adjuvant Chemotherapy in HER2-positive, Estrogen Receptor-negative, Node-negative Early Breast Cancer Patients Who Achieved Pathological Complete Response After Neoadjuvant Chemotherapy and Dual HER2 Blockade
Enrollment Status: Terminated
Publish Date: December 04, 2024
Intervention Type: Drug
Study Phase: Phase 2
Randomized Phase II Study Comparing Neo-epitope Based Vaccine OSE2101 (TEDOPI®) With or Without Anti-PD1 (Pembrolizumab) Versus Best Supportive Care as Maintenance Treatment in Platinum-sensitive Recurrent Ovarian Cancer Patient With Controlled Disease After Platinum-based Chemotherapy
Randomized Phase II Study Comparing Neo-epitope Based Vaccine OSE2101 (TEDOPI®) With or Without Anti-PD1 (Pembrolizumab) Versus Best Supportive Care as Maintenance Treatment in Platinum-sensitive Recurrent Ovarian Cancer Patient With Controlled Disease After Platinum-based Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2024
Intervention Type: Drug
Study Drugs: OSE2101, Pembrolizumab [Keytruda]
Study Phase: Phase 2
KDOG1 :Transcutaneous Breast Cancer Diagnosis by Canine Odorology
KDOG1 :Transcutaneous Breast Cancer Diagnosis by Canine Odorology
Enrollment Status: Completed
Publish Date: July 14, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View 3 Less Clinical Trials

79 Total Publications

Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers.
Fertility preservation in gynecologic oncology: evaluating knowledge, practices, and barriers among French healthcare providers.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 02, 2025

Frequently Asked Questions about Elise Deluche

Is Elise Deluche a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Elise Deluche is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Elise Deluche participate in research or clinical trials?

Yes. Elise Deluche has published 79 articles and abstracts on conditions like Breast Cancer. You can view a list of Elise Deluche's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Deluche's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile